Drug Type Antibody drug conjugate (ADC) |
Synonyms AT 01, AT 86474, AT01 + [1] |
Target |
Action antagonists |
Mechanism ROR1 antagonists(Inactive tyrosine-protein kinase transmembrane receptor ROR1 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hematologic Neoplasms | Preclinical | China | 11 May 2024 | |
Solid tumor | Preclinical | China | 11 May 2024 |